We provide a more complete picture of disease risk through clinical-grade whole genome sequencing (up to 30x) and analysis.
https://www.myome.com/These are collections MyOme is a part of. Click on the collection name to view similar companies.
Series B
$23,000,000
0 out of 5 stars
Based on 0 reviews
Worked here? Share your experience. Help others decide if this company is right for them. Write a review on MyOme.